Low-income Brits agree to be injected with experimental Ebola vaccine for barely enough money to pay one month’s rent

Friday, November 13, 2015
By Paul Martin

by: J. D. Heyes
Friday, November 13, 2015

It might seem like a death sentence you wouldn’t accept for any amount of money, but some lower-income British citizens appear to believe the risk is worth the reward.

As reported by the UK’s Daily Mail, a medical research lab is searching for Brits who will voluntarily agree to be injected with the Ebola virus as part of research into finding a cure for the generally fatal disease.

The research firm, Hammersmith Medical Research, began holding clinical trials at the beginning of November to develop an immunization vaccine that scientists hope will prevent future Ebola infections.

There is currently no known or licensed treatment or vaccine for Ebola, which has killed more than 11,000 people so far in West Africa since the globe’s largest outbreak began in a forested region of Guinea in December 2013. The disease managed to spread to the U.S. and elsewhere, but it never became as prevalent or deadly as it has been to West African nations Guinea and Sierra Leone.

The paper noted that the prestigious Oxford University held similar clinical trials involving healthy people who agreed to be injected with a single protein from the Ebola virus in order to trigger an immune response and serum for a potential vaccine.

For the current trial, organizers said they are looking for people in London between the ages of 18 and 65 to take part on the trial, which begins later this month. An advertisement for volunteers placed in The Evening Standard says, “Interested in helping medical research into a vaccine for Ebola virus and being paid for your help? Are you 18-65 years old and in good health? If the answer is YES, then you might be suitable for a study of an Ebola vaccine.”

The Rest…HERE

Comments are closed.

Join the revolution in 2018. Revolution Radio is 100% volunteer ran. Any contributions are greatly appreciated. God bless!

Follow us on Twitter